T1	Participants 13 51	hypervascular hepatocellular carcinoma
T2	Participants 246 284	hypervascular hepatocellular carcinoma
T3	Participants 430 545	The study included 149 patients, among whom 36 patients with hypervascular hepatocellular carcinoma were identified
T4	Participants 1754 1778	hepatocellular carcinoma
